In this study, we aim to investigate whether quantitative parameters of synthetic MRI can be used to differentiate among molecular subtypes and prognostic factors in patients with breast cancer. It was concluded that SD of PD-Pre was significantly different between HER2-enriched and non-HER2-enriched breast cancers, which displayed optimal performance than others. Quantitative T2-Pre, T2-Gd, SD of PD-Pre, and SD of PD-Gd were significantly different in the molecular subtypes and can further differentiate luminal breast cancers from non-luminal subtypes. T1-Pre, T2-Pre, and SD of PD-Gd were significantly different between triple negative (TN) and non-TN breast cancers.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords